View Item 

Show simple item record

Assessing methylphenidate preference in ADHD patients using a choice procedure
dc.contributor.authorFredericks, Emily MacDonalden_US
dc.contributor.authorKollins, Scott H.en_US
dc.date.accessioned2006-09-11T17:41:27Z
dc.date.available2006-09-11T17:41:27Z
dc.date.issued2004-10en_US
dc.identifier.citationFredericks, Emily MacDonald; Kollins, Scott H.; (2004). "Assessing methylphenidate preference in ADHD patients using a choice procedure." Psychopharmacology 175(4): 391-398. <http://hdl.handle.net/2027.42/46361>en_US
dc.identifier.issn0033-3158en_US
dc.identifier.issn1432-2072en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/46361
dc.identifier.urihttp://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=15258716&dopt=citationen_US
dc.description.abstractMethylphenidate (MPH) is widely used in the treatment of attention deficit hyperactivity disorder (ADHD) and is associated with positive clinical effects across a wide range of domains. Despite the clinical effectiveness of MPH, concern has arisen with respect to its abuse potential.en_US
dc.format.extent173905 bytes
dc.format.extent3115 bytes
dc.format.mimetypeapplication/pdf
dc.format.mimetypetext/plain
dc.language.isoen_US
dc.publisherSpringer-Verlagen_US
dc.subject.otherMedicineen_US
dc.subject.otherReinforcing Effectsen_US
dc.subject.otherADHDen_US
dc.subject.otherMethylphenidateen_US
dc.subject.otherDrug Preferenceen_US
dc.subject.otherAbuse Potentialen_US
dc.titleAssessing methylphenidate preference in ADHD patients using a choice procedureen_US
dc.typeArticleen_US
dc.subject.hlbsecondlevelPsychiatryen_US
dc.subject.hlbsecondlevelNeurosciencesen_US
dc.subject.hlbsecondlevelChemistryen_US
dc.subject.hlbsecondlevelBiological Chemistryen_US
dc.subject.hlbtoplevelScienceen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationumDepartment of Pediatrics, University of Michigan Health System, 1924 Taubman Center, P.O. Box 0318, Ann Arbor, MI, 48109-0318, USAen_US
dc.contributor.affiliationotherDuke University Medical Center, Duke Child and Family Study Center, P.O. Box 3431, Durham, NC, 27710, USAen_US
dc.contributor.affiliationumcampusAnn Arboren_US
dc.identifier.pmid15258716en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/46361/1/213_2004_Article_1838.pdfen_US
dc.identifier.doihttp://dx.doi.org/10.1007/s00213-004-1838-2en_US
dc.identifier.sourcePsychopharmacologyen_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
213_2004_Article_1838.pdf
Size:
169.8KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.